Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BBD reports Q3 results on October 22 with two sharply divergent signals: insiders loaded up on shares last month while borrowing costs jumped more than fifteen-fold in a single day.
The most striking development in the lending market is the cost-to-borrow spike. BBD's borrow rate hit 4.88% on October 15, up from just 0.30% a week earlier, a move of more than 1,500% in seven days. That said, the broader lending pool remains loose. Availability runs at nearly 1,954%, meaning shares to borrow vastly outnumber those already lent. Short interest has also been falling, down roughly 12% over the past month to around 21.7 million shares, with the ORTEX short score climbing to 39.4 from 27.7 ten days ago, a move that signals building, though not extreme, short-side attention. Options positioning has tilted modestly more defensive ahead of the print. The put/call ratio edged up to 0.97, above its 20-day average of 0.91, though the z-score of 0.46 puts this well within normal range. Shares fell nearly 8% on the week to $3.96, paring a 13% monthly gain.
The analyst picture is divided. HSBC downgraded BBD to Hold from Buy on October 8, setting a $3.90 target, essentially at the current price. JP Morgan moved the other way two days earlier, upgrading to Overweight from Neutral. That tug-of-war at the bellwether level captures the broader debate. Bulls point to Bradesco's position as Brazil's second-largest private bank, holding 10% to 15% of national deposits and a 20% to 25% share of the domestic insurance market, alongside improved forecasts for earnings and free cash flow through 2027. Bears cite a reported 35% year-over-year drop in orders and a book-to-bill ratio of 0.9x, implying new business is not covering the pace of revenue generation. At a price-to-earnings multiple of 7.6 and price-to-book of 1.1, the stock is priced for caution rather than recovery, and the analyst recommendation score ranks in the 90th percentile for divergence across the universe.
The most concrete pre-earnings signal comes from insiders. Six executives, including multiple executive officers, made open-market purchases in September worth a combined $6.6 million, with the largest single transaction a purchase of 96,702 shares at $17.98. Net insider buying over the past 90 days totals roughly $98 million across 5.6 million shares, all on a non-10b5-1 basis, meaning discretionary rather than pre-planned. The trades were in the Brazilian-listed shares rather than the ADR, so the price points differ from the $3.96 ADR close, but the direction is unambiguous. That scale of coordinated discretionary buying from the management team is one of the more concrete signals in the setup.
Earnings history adds further texture. The last four prints all produced negative first-day moves, ranging from minus 2.3% to minus 3.2%, with five-day losses averaging around 8.5%. The October 22 print will test whether Bradesco's ongoing credit recovery and margin trajectory are sufficient to break that pattern, or whether macro headwinds in Brazil once again pull the stock lower despite the management team's own conviction.
See the live data behind this article on ORTEX.
Open BBD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
